NexEos Bio

NexEos’ lead therapeutic NTX-1024 is a topical ophthalmic solution designed to target and inhibit cationic granule proteins in eosinophil-driven ocular disease. From company website Source · Oct 13, 2026

Keywords: ophthalmic